News

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…

London & Manchester, UK, 27 November, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company…

A GENE previously identified as playing a role in eczema, asthma, and allergic rhinitis has been pinpointed as being associated with the incidence of…

EXPOSURE of pregnant mothers to dogs, as well as early contact between children and canine-specific bacteria, may reduce the risk of childhood eczema and…

AN UNMET need in prostate cancer patients could be filled following the extension of European Commission (EC) marketing authorisation of the combination…

DEMENTIA risk is substantially reduced in older adults if they receive computerised speed of processing training, a method previously shown to be…

LIVER tumour models have been grown in a lab for the first time, making it easier for researchers to better understand the biology of the disease and…